Tomari Kouki, Goto Masahiro, Shimada Aya, Yagi Hiroko, Nagashima Yuka, Hasegawa Yukihiro
Division of General Pediatrics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Clin Pediatr Endocrinol. 2017;26(4):265-269. doi: 10.1297/cpe.26.265. Epub 2017 Sep 28.
There are three major therapeutic options for the treatment of Graves' disease (GD): antithyroid drugs (ATDs), thyroidectomy, and radio-iodine (RAI) therapy. ATDs are the initial treatment option for children. However, some pediatric GD patients who are initially treated with ATDs require other type of treatments later on. We reviewed the medical records of childhood-onset GD cases retrospectively to report the clinical course of patients who received either surgery or RAI therapy subsequent to treatment with ATDs. Childhood-onset GD was successfully managed in five girls with non-ATD treatments at the age of 7-14 yr following an unfavorable outcome of initial ATD treatment. Four cases had surgery and one case was managed with RAI therapy. The reasons for switching to non-ATD treatment included poor compliance, failure to maintain remission, serious adverse events resulting from ATDs, and religious background. In conclusion, surgery and RAI therapy could be good alternative treatment options for children with GD.
治疗格雷夫斯病(GD)有三种主要的治疗选择:抗甲状腺药物(ATD)、甲状腺切除术和放射性碘(RAI)治疗。ATD是儿童的初始治疗选择。然而,一些最初接受ATD治疗的儿科GD患者后来需要其他类型的治疗。我们回顾性地查阅了儿童期发病的GD病例的病历,以报告在接受ATD治疗后接受手术或RAI治疗的患者的临床病程。5名女童在初始ATD治疗效果不佳后,于7至14岁时通过非ATD治疗成功控制了儿童期发病的GD。4例接受了手术,1例接受了RAI治疗。改用非ATD治疗的原因包括依从性差、无法维持缓解、ATD引起的严重不良事件以及宗教背景。总之,手术和RAI治疗可能是GD患儿良好的替代治疗选择。